These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9259041)

  • 1. Immune effects of relaxation during chemotherapy for ovarian cancer.
    Lekander M; Fürst CJ; Rotstein S; Hursti TJ; Fredrikson M
    Psychother Psychosom; 1997; 66(4):185-91. PubMed ID: 9259041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune function in patients with ovarian carcinoma treated with irradiation or with cytostatics.
    Toivanen A; Grönroos M; Lassila O; Nordman E
    Acta Obstet Gynecol Scand; 1984; 63(2):153-8. PubMed ID: 6375243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of psychological intervention in the form of relaxation and guided imagery on cellular immune function in normal healthy subjects. An overview.
    Zachariae R; Kristensen JS; Hokland P; Ellegaard J; Metze E; Hokland M
    Psychother Psychosom; 1990; 54(1):32-9. PubMed ID: 2091031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trait anxiety and anticipatory immune reactions in women receiving adjuvant chemotherapy for breast cancer.
    Fredrikson M; Fürst CJ; Lekander M; Rotstein S; Blomgren H
    Brain Behav Immun; 1993 Mar; 7(1):79-90. PubMed ID: 8471800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations on cell-mediated immunity in patients with breast and ovarian carcinomas receiving a combination of chemotherapy and immunotherapy with thymopentin.
    Mallmann P; Krebs D
    Methods Find Exp Clin Pharmacol; 1990 Jun; 12(5):333-40. PubMed ID: 2232966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer.
    Tas F; Yildiz I; Kilic L; Ciftci R; Keskin S; Sen F
    Am J Ther; 2016; 23(3):e670-9. PubMed ID: 23782755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life evaluations in patients with ovarian cancer during chemotherapy treatment.
    Le T; Leis A; Pahwa P; Wright K; Ali K; Reeder B; Hopkins L; Fung MF
    Gynecol Oncol; 2004 Mar; 92(3):839-44. PubMed ID: 14984950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-modulatory effects of relaxation training and guided imagery in women with locally advanced breast cancer undergoing multimodality therapy: a randomised controlled trial.
    Eremin O; Walker MB; Simpson E; Heys SD; Ah-See AK; Hutcheon AW; Ogston KN; Sarkar TK; Segar A; Walker LG
    Breast; 2009 Feb; 18(1):17-25. PubMed ID: 19008099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cimetidine on natural killer activity of peripheral blood lymphocytes of patients with ovarian carcinoma.
    Kikuchi Y; Oomori K; Kizawa I; Kato K
    Jpn J Clin Oncol; 1985 Jun; 15(2):377-83. PubMed ID: 3839542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological stress predicts the risk of febrile episodes in cancer patients during chemotherapy.
    Pedersen AF; Zachariae R; Jensen AB; Bovbjerg DH; Andersen O; von der Maase H
    Psychother Psychosom; 2009; 78(4):258-60. PubMed ID: 19468261
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy.
    Walker LG; Walker MB; Ogston K; Heys SD; Ah-See AK; Miller ID; Hutcheon AW; Sarkar TK; Eremin O
    Br J Cancer; 1999 Apr; 80(1-2):262-8. PubMed ID: 10390006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegfilgrastim dosing on same day as myelosuppressive chemotherapy for ovarian or primary peritoneal cancer.
    Schuman SI; Lambrou N; Robson K; Glück S; Myriounis N; Pearson JM; Lucci JA
    J Support Oncol; 2009; 7(6):225-8. PubMed ID: 20380330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy.
    Sieja K; Talerczyk M
    Gynecol Oncol; 2004 May; 93(2):320-7. PubMed ID: 15099940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social support, psychological distress, and natural killer cell activity in ovarian cancer.
    Lutgendorf SK; Sood AK; Anderson B; McGinn S; Maiseri H; Dao M; Sorosky JI; De Geest K; Ritchie J; Lubaroff DM
    J Clin Oncol; 2005 Oct; 23(28):7105-13. PubMed ID: 16192594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of lenograstim (Granocyte) in chemotherapy for ovarian cancer.
    Roongpisuthipong A; Suphanit I; Luamprapat A; Senapad S
    Asian Pac J Allergy Immunol; 1998 Mar; 16(1):43-7. PubMed ID: 9681128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic determinants of head and neck cancer response to induction chemotherapy.
    Schantz SP; Savage HE; Racz T; Liu FJ; Brown BW; Rossen RD; Hong WK
    J Clin Oncol; 1989 Jul; 7(7):857-64. PubMed ID: 2472470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of topotecan-based chemotherapy on the immune system of advanced ovarian cancer patients: an immunophenotypic study.
    Ferrari S; Rovati B; Cucca L; Scarabelli C; Presti M; Beccaria C; Collovà E; Porta C; Danova M
    Oncol Rep; 2002; 9(5):1107-13. PubMed ID: 12168081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer: a solid tumor with evidence of normal cellular immune function but abnormal B cell function.
    Mandell GL; Fisher RI; Bostick F; Young RC
    Am J Med; 1979 Apr; 66(4):621-4. PubMed ID: 312015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian carcinoma: modification of T4 lymphocytes after surgery and during chemotherapy.
    Bogavac M; Baltić V; Aleksić S; Baltić M; Potić Z
    J Chemother; 1996 Jun; 8(3):229-31. PubMed ID: 8808722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The hematopoietic growth factor GM-CSF in chemotherapy for ovarian carcinoma].
    Biesma B; Willemse PH; Vellenga E; Limburg PC; Aalders JG; de Vries EG
    Ned Tijdschr Geneeskd; 1991 Mar; 135(10):420-4. PubMed ID: 2020314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.